Geriatric depression and vascular diseases: what are the links?

Vincent Camus1, Hélène Kraehenbühl, Martin Preisig

  • 1Department of Geriatric Psychiatry, University Hospital, Lausanne CH-1011, Switzerland. V.Camus@chu-tours.fr

Insights

Vascular depression, a condition in older adults, is linked to cerebrovascular disease. This review explores the bidirectional relationship between geriatric depression and vascular diseases, including shared risk factors and mechanisms.

Area of Science:

  • Geriatric psychiatry
  • Cardiovascular medicine
  • Neuroscience

Background:

  • Vascular depression is a proposed subtype of late-life depression linked to cerebrovascular disease.
  • Depression can also precede, worsen, or result from cardiovascular diseases and increase vascular risk factors like diabetes.

Purpose of the Study:

  • To review clinical and epidemiological evidence connecting geriatric depression and vascular diseases.
  • To explore potential underlying mechanisms of this association.

Main Methods:

  • Systematic literature review.
  • Medline database search of the last 5 years.

Main Results:

  • Vascular disease, particularly arteriosclerosis, may directly influence depression incidence.
  • Depressive disorders can directly impact the cardiovascular system.
  • Depression and vascular disease may share common pathophysiological processes or genetic factors.

Conclusions:

  • While vascular depression is often seen as a consequence of brain lesions, this doesn't explain depression preceding vascular disease.
  • Geriatric depression may arise from vascular brain lesions and share pathogenic or genetic determinants with cardiovascular diseases.
Abstract

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...